Have a personal or library account? Click to login
The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome Cover

The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome

Open Access
|Jul 2023

References

  1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
  2. Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924.
  3. Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–83.
  4. Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS One. 2018;13(3):e0194127.
  5. Damiri B, Badran L, Safadi D, Sawalha A, Yasin Y, Sawalha M, et al. Metabolic syndrome and related risk factors among adults in the northern West Bank, a cross-sectional study. Int Health. 2022;14(4):339–45.
  6. Tavares AM, Silva JH, Bensusan C de O, Ferreira ACF, Matos LP de L, e Souza KL de A, et al. Altered superoxide dismutase-1 activity and intercellular adhesion molecule 1 (ICAM-1) levels in patients with type 2 diabetes mellitus. PLoS One. 2019;14(5):e0216256.
  7. Hebert-Schuster M, Fabre EE, Nivet-Antoine V. Catalase polymorphisms and metabolic diseases. Curr Opin Clin Nutr Metab Care. 2012;15(4):397–402.
  8. Raina P, Sikka R, Gupta H, Matharoo K, Bali SK, Singh V, et al. Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study. Biochem Genet. 2021;59(4):966–96.
  9. Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ, et al. The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab. 2005;84(1):83–9.
  10. Xi B, Ruiter R, Chen J, Pan H, Wang Y, Mi J. The ACE insertion/deletion polymorphism and its association with metabolic syndrome. Metabolism. 2012;61(6):891–7.
  11. Alavi-Shahri J, Behravan J, Hassany M, Tatari F, Kasaian J, Ganjali R, et al. Association between angiotensin II type 1 receptor gene polymorphism and metabolic syndrome in a young female Iranian population. Arch Med Res. 2010;41(5):343–9.
  12. Hou L, Quan X, Li X, Su X. Correlation between gene polymorphism in angiotensin II type 1 receptor and type 2 diabetes mellitus complicated by hypertension in a population of Inner Mongolia. BMC Med Genet. 2020;21(1):83.
  13. Saravani R, Esmaeeli E, Kordi Tamendani M, Nejad MN. Oxytocin Receptor Gene Polymorphisms in Patients With Diabetes. Gene, Cell Tissue. 2015;2(2):e60171.
  14. Winterton A, Bettella F, de Lange A-MG, Haram M, Steen NE, Westlye LT, et al. Oxytocin-pathway polygenic scores for severe mental disorders and metabolic phenotypes in the UK Biobank. Transl Psychiatry. 2021;11(1):599.
  15. Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016;37(3):278–316.
  16. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol. 2006;95(3):136–47.
  17. Chamberlain JJ, Rhinehart AS, Shaefer CFJ, Neuman A. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2016;164(8):542–52.
  18. Akcay A, Sezer S, Ozdemir FN, Arat Z, Atac FB, Verdi H, et al. Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation. 2004;78(6):892–8.
  19. Truzzi A, Poquérusse J, Setoh P, Shinohara K, Bornstein MH, Esposito G. Oxytocin receptor gene polymorphisms (rs53576) and early paternal care sensitize males to distressing female vocalizations. Dev Psychobiol. 2018;60(3):333–9.
  20. Saygi S, Erol İ, Alehan F, Yalçın YY, Kubat G, Ataç FB. Superoxide Dismutase and Catalase Genotypes in Pediatric Migraine Patients. J Child Neurol. 2015;30(12):1586–90.
  21. Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):119.
  22. Lewandowski Ł, Kepinska M, Milnerowicz H. Alterations in Concentration/Activity of Superoxide Dismutases in Context of Obesity and Selected Single Nucleotide Polymorphisms in Genes: SOD1, SOD2, SOD3. Int J Mol Sci. 2020;21(14):5069
  23. Panduru NM, Cimponeriu D, Cruce M, Ion DA, Moţa E, Moţa M, et al. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes. Rom J Morphol Embryol. 2010;51(1):37–41.
  24. Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet. 2008;9:30.
  25. Lewandowski Ł, Urbanowicz I, Kepinska M, Milnerowicz H. Concentration/activity of superoxide dismutase isozymes and the pro-/antioxidative status, in context of type 2 diabetes and selected single nucleotide polymorphisms (genes: INS, SOD1, SOD2, SOD3) - Preliminary findings. Biomed Pharmacother. 2021;137:111396.
  26. El Alami H, Ghazal H, Abidi O, Al Idrissi N, Wakrim L, Naamane A, et al. Relationship between insertion/deletion (I/D) polymorphism of angiotensin converting enzyme (ACE) gene and susceptibility to type 2 diabetes mellitus in the Middle East and North Africa Region: A meta-analysis. Diabetes Metab Syndr. 2022;16(1):102386.
  27. Zarouk WA, Hussein IR, Esmaeil NN, Raslan HM, Reheim HAA, Moguib O, et al. Association of angiotensin converting enzyme gene (I/D) polymorphism with hypertension and type 2 diabetes. Bratisl Lek Listy. 2012;113(1):14–8.
  28. Ramachandran V, Ismail P, Stanslas J, Shamsudin N, Moin S, Mohd Jas R. Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects. J Renin Angiotensin Aldosterone Syst. 2008;9(4):208–14.
  29. Zhou L, Xue Y, Luo R, Gao F. [Association of insertion/deletion polymorphism in angiotensin-converting enzyme gene with hypertensive type 2 diabetes mellitus]. Di Yi Jun Yi Da Xue Xue Bao. 2002;22(9):808–10.
  30. Araz M, Aynacioglu S, Aktaran S, Alasehirli B, Okan V. Association between polymorphism of the angiotensin I converting enzyme gene and hypertension in Turkish type II diabetic patients. Acta medica(Hradec Kralove). 2001;44(1):29–32.
  31. Alsafar H, Hassoun A, Almazrouei S, Kamal W, Almaini M, Odama U, et al. Association of Angiotensin Converting Enzyme Insertion-Deletion Polymorphism with Hypertension in Emiratis with Type 2 Diabetes Mellitus and Its Interaction with Obesity Status. Dis Markers. 2015;2015:536041.
  32. Ahmad N, Jamal R, Shah SA, Gafor AHA, Murad NAA. Renin-Angiotensin-Aldosterone System Gene Polymorphisms and Type 2 Diabetic Nephropathy in Asian Populations: An Updated Meta-analysis. Curr Diabetes Rev. 2019;15(4):263–76.
  33. Al-Rubeaan K, Siddiqui K, Saeb ATM, Nazir N, Al-Naqeb D, Al-Qasim S. ACE I/D and MTHFR C677T polymorphisms are significantly associated with type 2 diabetes in Arab ethnicity: A meta-analysis. Gene. 2013;520(2):166–77.
  34. Niu W, Qi Y, Gao P, Zhu D. Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis. Endocr J. 2010;57(5):431–8.
  35. Jalil JE, Córdova S, Ocaranza M a, Schumacher E, Braun S, Chamorro G, et al. Angiotensin I-converting enzyme insertion/deletion polymorphism and adrenergic response to exercise in hypertensive patients. Med Sci Monit. 2002;8(8):CR566–71.
  36. Srinivasa S, Aulinas A, O’Malley T, Maehler P, Adler GK, Grinspoon SK, et al. Oxytocin response to controlled dietary sodium and angiotensin II among healthy individuals. Am J Physiol Endocrinol Metab. 2018;315(4):E671–5.
  37. Bealer SL, Crowley WR. Angiotensin II-induced release of oxytocin: interaction with norepinephrine and role in lactation. Regul Pept. 2003;111(1):41–6.
  38. Dietze GJ, Henriksen EJ. Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis. J Renin Angiotensin Aldosterone Syst. 2008;9(2):75–88.
  39. McQuaid RJ, McInnis OA, Matheson K, Anisman H. Distress of ostracism: oxytocin receptor gene polymorphism confers sensitivity to social exclusion. Soc Cogn Affect Neurosci. 2015;10(8):1153–9.
  40. Chang HH, Chang WH, Chi MH, Peng YC, Huang C-C, Yang YK, et al. The OXTR Polymorphism Stratified the Correlation of Oxytocin and Glucose Homeostasis in Non-Diabetic Subjects. Diabetes Metab Syndr Obes. 2019;12:2707–13.
  41. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123–32.
Language: English
Page range: 21 - 26
Published on: Jul 31, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2023 C Zenoaga-Barbăroșie, L Berca, T Vassu-Dimov, M Toma, MI Nica, OA Alexiu-Toma, C Ciornei, A Albu, S Nica, C Nistor, R Nica, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.